BioScience Health Innovations Income Statement (2019-2025) | BHIC

Income Statement Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.03M0.07M0.19M0.30M0.28M0.38M0.57M0.61M1.23M1.76M1.13M1.57M
Cost of Revenue (Quarter) 0.00M0.01M0.03M0.07M0.04M0.07M0.15M0.27M0.33M0.68M0.43M1.00M
Gross Profit (Quarter) 0.03M0.06M0.16M0.24M0.23M0.31M0.42M0.34M0.90M1.07M0.70M0.57M
Operating items
Selling, General & Administrative (Quarter) 0.00M0.00M0.00M0.01M0.01M0.00M0.00M0.01M0.03M0.05M0.03M0.09M0.14M0.21M0.26M0.28M0.22M0.35M0.30M0.43M0.54M0.58M0.66M
Other Operating Expenses (Quarter) 0.09M0.01M0.01M0.01M0.02M0.03M0.04M0.08M0.13M0.07M
Operating Expenses (Quarter) 0.00M0.00M0.00M0.01M0.01M0.00M0.00M0.01M0.03M0.05M0.03M0.10M0.15M0.22M0.27M0.29M0.24M0.37M0.33M0.47M0.62M0.71M0.73M
Operating Income (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.03M-0.05M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M
EBIT (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.03M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M
Non-operating items
Non Operating Income (Quarter) 0.01M
Net income details
EBT (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M
Profit After Tax (Quarter) -0.00M-0.00M-0.01M-0.01M-0.01M-0.00M-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.23M
Income from Continuing Operations (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M
Consolidated Net Income (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M
Income towards Parent Company (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M
Net Income towards Common Stockholders (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.02M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M
Additional items
EPS (Basic) (Quarter) 0.000.000.000.000.000.000.000.000.00-0.010.00-0.01-0.010.000.000.000.000.000.010.000.010.010.00-0.02
EPS (Weighted Average and Diluted) (Quarter) 0.000.000.000.000.010.000.010.010.00-0.02
Shares Outstanding (Weighted Average) (Quarter) 2.80M2.90M3.26M3.79M5.46M5.46M5.46M5.46M5.46M5.46M5.46M5.46M5.46M13.86M26.78M40.36M33.76M41.39M41.60M10.47M10.48M43.92M43.92M10.98M10.98M
Shares Outstanding (Diluted Average) (Quarter) 31.43M33.76M41.39M42.02M10.89M10.90M44.34M44.34M11.40M11.40M
EBITDA (Quarter) -0.00M-0.00M-0.00M-0.01M-0.01M-0.00M-0.00M-0.01M-0.03M-0.05M-0.00M-0.03M-0.07M-0.09M-0.06M-0.04M-0.05M0.07M0.06M0.01M0.43M0.46M-0.01M-0.16M